| 1 | Neutral rhenium(<scp>i</scp>) tricarbonyl complexes with sulfur-donor ligands: anti-proliferative activity and cellular localization | 3.2 | 2 | Citations (PDF) |
| 2 | Fluorescent, phosphorescent, magnetic resonance contrast and radioactive tracer labelling of extracellular vesicles | 38.2 | 18 | Citations (PDF) |
| 3 | Tetranuclear Polypyridylruthenium(II) Complexes as Selective Nucleic Acid Stains for Flow Cytometric Analysis of Monocytic and Epithelial Lung Carcinoma Large Extracellular Vesicles | 4.4 | 0 | Citations (PDF) |
| 4 | Halogenated non-innocent vanadium(<scp>v</scp>) Schiff base complexes: chemical and anti-proliferative properties | 2.5 | 10 | Citations (PDF) |
| 5 | Synthesis and the photophysical and biological properties of tricarbonyl Re(<scp>i</scp>) diimine complexes bound to thiotetrazolato ligands | 3.2 | 2 | Citations (PDF) |
| 6 | Anti‐Migratory and Cytotoxic Activities of [Ga(8‐hydroxyquinolinato)3]: Roles of Endogenous Cu(II) and Drug‐Induced Phenotypic Changes. | 3.4 | 0 | Citations (PDF) |
| 7 | A tetranuclear polypyridylruthenium(<scp>ii</scp>) complex as a selective stain for extracellular vesicle penetration through brain microvascular endothelium | 4.2 | 2 | Citations (PDF) |
| 8 | Vanadium(V) Pyridine‐Containing Schiff Base Catecholate Complexes are Lipophilic, Redox‐Active and Selectively Cytotoxic in Glioblastoma (T98G) Cells | 3.4 | 16 | Citations (PDF) |
| 9 | Substitution Kinetics, Albumin and Transferrin Affinities, and Hypoxia All Affect the Biological Activities of Anticancer Vanadium(V) Complexes | 4.6 | 14 | Citations (PDF) |
| 10 | Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections | 5.2 | 32 | Citations (PDF) |
| 11 | Urea Gel Electrophoresis in Studies of Conformational Changes of Transferrin on Binding and Transport of Non-Ferric Metal Ions | 4.9 | 9 | Citations (PDF) |
| 12 | Controversial Role of Transferrin in the Transport of Ruthenium Anticancer Drugs | 4.4 | 22 | Citations (PDF) |
| 13 | Vanadium Chloro-Substituted Schiff Base Catecholate Complexes are Reducible, Lipophilic, Water Stable, and Have Anticancer Activities | 4.6 | 25 | Citations (PDF) |
| 14 | Ruthenium(II)–Arene Thiocarboxylates: Identification of a Stable Dimer Selectively Cytotoxic to Invasive Breast Cancer Cells | 2.7 | 10 | Citations (PDF) |
| 15 | A Short‐Lived but Highly Cytotoxic Vanadium(V) Complex as a Potential Drug Lead for Brain Cancer Treatment by Intratumoral Injections | 1.5 | 10 | Citations (PDF) |
| 16 | Frontispiz: A Short‐Lived but Highly Cytotoxic Vanadium(V) Complex as a Potential Drug Lead for Brain Cancer Treatment by Intratumoral Injections | 1.5 | 0 | Citations (PDF) |
| 17 | Vanadium(V/IV)–Transferrin Binding Disrupts the Transferrin Cycle and Reduces Vanadium Uptake and Antiproliferative Activity in Human Lung Cancer Cells | 4.6 | 38 | Citations (PDF) |
| 18 | A Short‐Lived but Highly Cytotoxic Vanadium(V) Complex as a Potential Drug Lead for Brain Cancer Treatment by Intratumoral Injections | 14.9 | 67 | Citations (PDF) |
| 19 | Vanadium(V) tris-3,5-di-tert-butylcatecholato complex: Links between speciation and anti-proliferative activity in human pancreatic cancer cells | 3.0 | 39 | Citations (PDF) |
| 20 | Redox chemistry and biological activities of chromium(III) complexes 2019, , 281-321 | | 9 | Citations (PDF) |
| 21 | Hydrophobicity may enhance membrane affinity and anti-cancer effects of Schiff base vanadium(<scp>v</scp>) catecholate complexes | 3.2 | 61 | Citations (PDF) |
| 22 | Transferrin Cycle and Clinical Roles of Citrate and Ascorbate in Improved Iron Metabolism | 3.8 | 24 | Citations (PDF) |
| 23 | Reactivity and Transformation of Antimetastatic and Cytotoxic Rhodium(III)–Dimethyl Sulfoxide Complexes in Biological Fluids: An XAS Speciation Study | 4.6 | 17 | Citations (PDF) |
| 24 | Synthesis, characterization and <i>in vitro</i> anti-cancer activity of vanadium-doped nanocrystalline hydroxyapatite | 2.5 | 20 | Citations (PDF) |
| 25 | (Pentamethylcyclopentadienato)rhodium Complexes for Delivery of the Curcumin Anticancer Drug | 1.9 | 19 | Citations (PDF) |
| 26 | Stabilities and Biological Activities of Vanadium Drugs: What is the Nature of the Active Species? | 3.1 | 86 | Citations (PDF) |
| 27 | High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium | 2.5 | 62 | Citations (PDF) |
| 28 | Biospectroscopy for studying the influences of anti-diabetic metals (V, Cr, Mo, and W) to the insulin signaling pathway | 0.1 | 2 | Citations (PDF) |
| 29 | Speciation of metal drugs, supplements and toxins in media and bodily fluids controls in vitro activities | 23.4 | 215 | Citations (PDF) |
| 30 | Synthesis, reactivities and anti-cancer properties of ruthenium(II) complexes with a thiaether macrocyclic ligand | 2.8 | 7 | Citations (PDF) |
| 31 | Biospeciation of Cr(III) Nutritional Supplements in Biological Fluids | 0.3 | 2 | Citations (PDF) |
| 32 | Mass Spectrometry Analysis of Chromium-Binding Low-Molecular-Weight Serum Fractions | 0.4 | 0 | Citations (PDF) |
| 33 | Binding of Chromium(III) to Transferrin Could Be Involved in Detoxification of Dietary Chromium(III) Rather than Transport of an Essential Trace Element | 1.5 | 6 | Citations (PDF) |
| 34 | Carcinogenic Chromium(VI) Compounds Formed by Intracellular Oxidation of Chromium(III) Dietary Supplements by Adipocytes | 14.9 | 58 | Citations (PDF) |
| 35 | Comparison of KP1019 and NAMI-A in tumour-mimetic environments | 2.5 | 41 | Citations (PDF) |
| 36 | XAS spectroelectrochemistry: reliable measurement of X-ray absorption spectra from redox manipulated solutions at room temperature | 3.0 | 18 | Citations (PDF) |
| 37 | Binding of Chromium(III) to Transferrin Could Be Involved in Detoxification of Dietary Chromium(III) Rather than Transport of an Essential Trace Element | 14.9 | 55 | Citations (PDF) |
| 38 | Carcinogenic Chromium(VI) Compounds Formed by Intracellular Oxidation of Chromium(III) Dietary Supplements by Adipocytes | 1.5 | 7 | Citations (PDF) |
| 39 | Simultaneous biosynthesis of putrebactin, avaroferrin and bisucaberin by Shewanella putrefaciens and characterisation of complexes with iron(III), molybdenum(VI) or chromium(V) | 3.0 | 32 | Citations (PDF) |
| 40 | Reactivity and Speciation of Anti-Diabetic Vanadium Complexes in Whole Blood and Its Components: The Important Role of Red Blood Cells | 4.6 | 70 | Citations (PDF) |
| 41 | Vanadium(V) and -(IV) complexes of anionic polysaccharides: Controlled release pharmaceutical formulations and models of vanadium biotransformation products | 3.0 | 19 | Citations (PDF) |
| 42 | Biotransformations of Antidiabetic Vanadium Prodrugs in Mammalian Cells and Cell Culture Media: A XANES Spectroscopic Study | 4.6 | 59 | Citations (PDF) |
| 43 | Influence of an anti-metastatic ruthenium(<scp>iii</scp>) prodrug on extracellular protein–protein interactions: studies by bio-layer interferometry | 6.3 | 28 | Citations (PDF) |
| 44 | Reactivity–activity relationships of oral anti-diabetic vanadium complexes in gastrointestinal media: an X-ray absorption spectroscopic study | 2.5 | 42 | Citations (PDF) |
| 45 | Vanadium Speciation by XANES Spectroscopy: A Three‐Dimensional Approach | 3.4 | 50 | Citations (PDF) |
| 46 | Solid-State Structural Studies of Chromium(III) Nicotinato Nutritional Supplements | 4.6 | 13 | Citations (PDF) |
| 47 | Chromium | 0.0 | 8 | Citations (PDF) |
| 48 | Biotransformations of Anticancer Ruthenium(III) Complexes: An X‐Ray Absorption Spectroscopic Study | 3.4 | 67 | Citations (PDF) |
| 49 | Isolation, Characterization, and Nuclease Activity of Biologically Relevant Chromium(V) Complexes with Monosaccharides and Model Diols. Likely Intermediates in Chromium-Induced Cancers | 4.6 | 20 | Citations (PDF) |
| 50 | Synthesis and Characterization of a Chromium(V) <i>cis</i>-1,2-Cyclohexanediolato Complex: A Model of Reactive Intermediates in Chromium-Induced Cancers | 4.6 | 15 | Citations (PDF) |
| 51 | X-ray-induced photo-chemistry and X-ray absorption spectroscopy of biological samples | 3.0 | 154 | Citations (PDF) |
| 52 | Chemical alterations to murine brain tissue induced by formalin fixation: implications for biospectroscopic imaging and mapping studies of disease pathogenesis | 3.1 | 181 | Citations (PDF) |
| 53 | Metal-based anti-diabetic drugs: advances and challenges | 3.2 | 125 | Citations (PDF) |
| 54 | Studies on the Biotransformations and Biodistributions of Metal-Containing Drugs Using X-Ray Absorption Spectroscopy | 2.7 | 55 | Citations (PDF) |
| 55 | Biomedical applications of X-ray absorption and vibrational spectroscopic microscopies in obtaining structural information from complex systems | 3.0 | 35 | Citations (PDF) |
| 56 | Characterization of a Ruthenium(III)/NAMI‐A Adduct with Bovine Serum Albumin that Exhibits a High Anti‐Metastatic Activity | 1.5 | 21 | Citations (PDF) |
| 57 | Characterization of a Ruthenium(III)/NAMI‐A Adduct with Bovine Serum Albumin that Exhibits a High Anti‐Metastatic Activity | 14.9 | 116 | Citations (PDF) |
| 58 | Imaging Metals in Proteins by Combining Electrophoresis with Rapid X-ray Fluorescence Mapping | 3.8 | 53 | Citations (PDF) |
| 59 | Formation and Reactivity of Chromium(V)−Thiolato Complexes: A Model for the Intracellular Reactions of Carcinogenic Chromium(VI) with Biological Thiols | 15.7 | 42 | Citations (PDF) |
| 60 | Silicon nitride as a versatile growth substrate for microspectroscopic imaging and mapping of individual cells | 2.8 | 77 | Citations (PDF) |
| 61 | Recent developments in ruthenium anticancer drugs | 2.5 | 565 | Citations (PDF) |
| 62 | Chromium in Cancer and Dietary Supplements | 0.0 | 8 | Citations (PDF) |
| 63 | Chemical Properties and Toxicity of Chromium(III) Nutritional Supplements | 3.9 | 201 | Citations (PDF) |
| 64 | Reactivity of Chromium(III) Nutritional Supplements in Biological Media: An X-Ray Absorption Spectroscopic Study | 4.6 | 65 | Citations (PDF) |
| 65 | A potential role for protein tyrosine phosphatase inhibition by a RuIII–edta complex (edta = ethylenediaminetetraacetate) in its biological activity | 4.2 | 32 | Citations (PDF) |
| 66 | Post-translational Regulation of Human Indoleamine 2,3-Dioxygenase Activity by Nitric Oxide | 2.3 | 94 | Citations (PDF) |
| 67 | Redox chemistry and biological activities of chromium(III) complexes 2007, , 225-256 | | 15 | Citations (PDF) |
| 68 | X-ray Absorption and EPR Spectroscopic Studies of the Biotransformations of Chromium(VI) in Mammalian Cells. Is Chromodulin an Artifact of Isolation Methods? | 15.7 | 75 | Citations (PDF) |
| 69 | Reactivity of potential anti-diabetic molybdenum(VI) complexes in biological media: A XANES spectroscopic study | 3.0 | 34 | Citations (PDF) |
| 70 | Charge Distribution in Chromium and Vanadium Catecholato Complexes: X-ray Absorption Spectroscopic and Computational Studies | 4.6 | 47 | Citations (PDF) |
| 71 | The EPR pattern of CrV complexes of d-ribose derivatives | 2.4 | 8 | Citations (PDF) |
| 72 | Mechanistic studies of relevance to the biological activities of chromium | 23.4 | 229 | Citations (PDF) |
| 73 | Three-dimensional structure determination using multiple-scattering analysis of XAFS: applications to metalloproteins and coordination chemistry | 23.4 | 88 | Citations (PDF) |
| 74 | Time-dependent uptake, distribution and biotransformation of chromium(VI) in individual and bulk human lung cells: application of synchrotron radiation techniques | 2.5 | 69 | Citations (PDF) |
| 75 | Chromium(V) Complexes of Hydroxamic Acids: Formation, Structures, and Reactivities | 4.6 | 42 | Citations (PDF) |
| 76 | Chromium(V) Peptide Complexes: Synthesis and Spectroscopic Characterization | 4.6 | 23 | Citations (PDF) |
| 77 | Bonding in HNO-Myoglobin as Characterized by X-ray Absorption and Resonance Raman Spectroscopies | 15.7 | 91 | Citations (PDF) |
| 78 | Binding of chromium(VI) to histones: implications for chromium(VI)-induced genotoxicity | 2.5 | 50 | Citations (PDF) |
| 79 | X-ray Absorption Spectroscopic and Electrochemical Studies of Tris(catecholato(2−))chromate(V/IV/III) Complexes | 14.9 | 27 | Citations (PDF) |
| 80 | Biomimetic Oxidation of Chromium(III): Does the Antidiabetic Activity of Chromium(III) Involve Carcinogenic Chromium(VI)? | 14.9 | 84 | Citations (PDF) |
| 81 | X-ray Absorption Spectroscopic and Electrochemical Studies of Tris(catecholato(2−))chromate(V/IV/III) Complexes | 1.5 | 6 | Citations (PDF) |
| 82 | Biomimetic Oxidation of Chromium(III): Does the Antidiabetic Activity of Chromium(III) Involve Carcinogenic Chromium(VI)? | 1.5 | 7 | Citations (PDF) |
| 83 | Solution Structures of Chromium(VI) Complexes with Glutathione and Model Thiols | 4.6 | 65 | Citations (PDF) |
| 84 | X-ray Absorption Spectroscopic Studies of Chromium(V/IV/III)− 2-Ethyl-2-hydroxybutanoato(2−/1−) Complexes | 4.6 | 38 | Citations (PDF) |
| 85 | Synthesis and Characterization of a Chromium(V)cis-Dioxo Bis(1,10-phenanthroline) Complex and Crystal and Molecular Structures of Its Chromium(III) Precursor | 4.6 | 36 | Citations (PDF) |
| 86 | Structure and Reactivity of a Chromium(V) Glutathione Complex1 | 4.6 | 78 | Citations (PDF) |
| 87 | Synthesis of a Pyridinium Bis[citrato(2−)]oxochromate(V) Complex and Its Ligand-Exchange Reactions | 4.6 | 23 | Citations (PDF) |
| 88 | X-ray Absorption Spectroscopic Studies of Chromium Nitroso Complexes. Crystal and Molecular Structure of (Ph4P)3[Cr(NO)(NCS)5]·2.4(CH3)2CO | 4.6 | 25 | Citations (PDF) |
| 89 | Redox and ligand-exchange chemistry of chromium(vi/v)-methyl glycoside systems | 2.4 | 22 | Citations (PDF) |
| 90 | An Investigation of the Chromium Oxidation State of a Monoanionic Chromium Tris(catecholate) Complex by X-ray Absorption and EPR Spectroscopies | 4.6 | 24 | Citations (PDF) |
| 91 | Disproportionation of a Model Chromium(V) Complex Causes Extensive Chromium(III)-DNA Binding in Vitro | 3.9 | 33 | Citations (PDF) |
| 92 | Chromium(VI) Reduction by Catechol(amine)s Results in DNA Cleavage in Vitro: Relevance to Chromium Genotoxicity | 3.9 | 45 | Citations (PDF) |
| 93 | Studies on the genotoxicity of chromium: from the test tube to the cell | 23.4 | 190 | Citations (PDF) |
| 94 | Disproportionation and Nuclease Activity of Bis[2-ethyl-2-hydroxybutanoato(2−)]oxochromate(V) in Neutral Aqueous Solutions1 | 4.6 | 54 | Citations (PDF) |
| 95 | Characterization and X-ray Absorption Spectroscopic Studies of Bis[quinato(2−)]oxochromate(V)1 | 4.6 | 38 | Citations (PDF) |
| 96 | Reactions of Chromium(VI/V/IV) with Bis(O-ethyl-l-cysteinato-N,S)zinc(II): A Model for the Action of Carcinogenic Chromium on Zinc-Finger Proteins1 | 15.7 | 43 | Citations (PDF) |
| 97 | X-Ray absorption spectroscopic studies of the Cr(IV) 2-ethyl-2-hydroxybutanoato(1−) complex† | 4.2 | 9 | Citations (PDF) |
| 98 | In Vitro Plasmid DNA Cleavage by Chromium(V) and -(IV) 2-Hydroxycarboxylato Complexes | 3.9 | 57 | Citations (PDF) |
| 99 | An EPR Spectroscopic Study of Chromium(V) Oxalato Complexes in Aqueous Solutions. Mechanism of the Chromium(VI) Oxidation of Oxalic Acid | 4.6 | 43 | Citations (PDF) |
| 100 | Activation of Molecular Oxygen during the Reactions of Chromium(VI/V/IV) with Biological Reductants: Implications for Chromium-Induced Genotoxicities1 | 15.7 | 115 | Citations (PDF) |
| 101 | Stability and Ligand Exchange Reactions of Chromium(IV) Carboxylato Complexes in Aqueous Solutions1 | 4.6 | 66 | Citations (PDF) |
| 102 | Kinetics and Mechanism of Chromium(VI) Reduction to Chromium(III) byl-Cysteine in Neutral Aqueous Solutions | 4.6 | 83 | Citations (PDF) |
| 103 | Potassium dichromate-Adogen 464/sodium percarbonate in acetonitrile: a simple, effective, catalytic and inexpensive system for the oxidative cleavage of α-functionalized benzylic alcohols | 2.8 | 9 | Citations (PDF) |
| 104 | Enantioselective allylic oxidation in the presence of the catalytic system | 1.8 | 84 | Citations (PDF) |
| 105 | On the stability of the copper- (S)-proline catalyst in the enantioselective allylic acyloxylation of alkenes | 2.1 | 26 | Citations (PDF) |
| 106 | A Convenient One-Step Catalytic Method for Obtaining Optically Active 2-Cyclopentenyl Benzoate from Cyclopentene | 1.9 | 22 | Citations (PDF) |
| 107 | Chromium in Biology: Toxicology and Nutritional Aspects 0, , 145-250 | | 7 | Citations (PDF) |
| 108 | Potential Applications of Vanadium-Based Anticancer Drugs for Intratumoral Injections 0, 67, 10 | | 4 | Citations (PDF) |
